Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
LUNIT INC
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Lunit to Showcase 5 Abstracts at ESMO 2022
2022-09-05 21:00
Lunit AI Solution for Breast Cancer Detection Wins Commercial Approval in Taiwan
2022-08-25 23:13
Lunit Announces Financial Results for the First Half of 2022
2022-08-12 21:00
New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research
2022-08-01 21:00
AI-based Cancer Solution Pioneer Lunit Makes Market Debut
2022-07-21 21:00
Lunit to be Listed on KOSDAQ next week
2022-07-14 21:00
Cathay Life Insurance to Incorporate Lunit AI Solution for Chest X-Ray into Underwriting Workflow
2022-07-06 21:00
Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System
2022-07-04 21:00
Lunit Files Registration Statement for Initial Public Offering
2022-06-16 21:00
New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment
2022-05-27 08:30
Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment-Published in the European Journal of Cancer
2022-05-19 21:00
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting
2022-04-28 21:33
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ
2022-04-21 22:12
New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities
2022-04-06 21:44
Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology
2022-03-16 21:09
Baheya Foundation, Egypt's Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening
2022-01-18 13:00
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries
2021-12-27 23:00
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
2021-12-09 11:24
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
2021-11-25 22:00
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
2021-11-18 22:00
1
2
3
4
5